Cardio

Home / All Products / Cardio

A heart-healthy combo of 4Life Transfer Factor® and over 18 vitamins, minerals, and antioxidants*

Primary Support: Heart Health, Energy*

Secondary Support: Immune System, Antioxidant*
• Features Certified 4Life Transfer Factor® to educate immune cells*

• Provides support for a healthy heart and proper cardiovascular function*

• Supports healthy cholesterol levels already in the normal range*

• Contains a proprietary blend that includes coenzyme Q-10, ginkgo biloba, garlic, red rice yeast extract, and ginger oil
4Life Transfer Factor Cardio features 4Life’s exclusive Targeted Transfer Factor® technology and other ingredients specifically developed to maintain and support a healthy cardiovascular system. Along with the immune-enhancing benefits of 4Life Transfer Factor®, this combination of heart-healthy nutrients include coenzyme Q-10, ginkgo biloba, garlic, red rice yeast extract, and others to promote cholesterol levels already in the normal range.*
At 4Life, we’ve made a commitment to uphold the highest standards of product quality. We certify all 4Life Transfer Factor® products and will always strive to create products of the utmost quality and efficacy. We pledge to uphold the product design and manufacturing for every product we sell. When you purchase 4Life Transfer Factor products, you can rest assured that you’re getting the very best. In fact, we guarantee it. Click here to view the 4Life Transfer Factor guarantee.

DSN
"My favorite Targeted Transfer Factor product is 4Life Transfer Factor Cardio. It gives me peace of mind that I am doing something good for my heart. Both my husband and I have family histories of heart conditions. We think it’s wonderful to have this product."*

Arlene Hubersberger,
4Life distributor
New Mexico, USA
Ensures exclusivity with protective United States patents: #6,468,534 (extraction process for transfer factors from egg sources) and #7,815,943 (a composition patent that protects the 4Life Transfer Factor® Cardio formula and ensures long-term exclusivity through 2025).